Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Ke Sheng, Ph.D.
Ke Sheng, Ph.D.

Affiliation(s):

Associate Clinical Professor, Department of Radiation Oncology
Member, JCCC Cancer Nanotechnology Program Area

Contact Information:

Phone:
(310) 983-3146
Email:

Scientific Interest(s):

Dr. Ke Sheng is interested in using ionizing radiation as a remote triggering device for therapeutic drug delivery.

Selected Cancer-Related Publications:

Yang W, Jones R, Lu W, Geesey C, Benedict S, Read P, Larner J, Sheng K. Feasibility of non-coplanar tomotherapy for lung cancer stereotactic body radiation therapy. Technol Cancer Res Treat. 2011 Aug;10(4):307-15.

Cai J, McLawhorn R, Altes TA, Lange ED, Read PW, Larner JM, Benedict SH, Sheng K. Helical Tomotherapy Planning for Lung Cancer Based on Ventilation Magnetic Resonance Imaging. Med Dosim. 2011 Mar 4. [Epub ahead of print]

Shoushtari A, Saylor D, Kerr KL, Sheng K, Thomas C, Jameson M, Reibel J, Shonka D, Levine P, Read P. Outcomes of Patients with Head-and-Neck Cancer of Unknown Primary Origin Treated with Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 4. [Epub ahead of print]

Wang L, Yang W, Read P, Larner J, Sheng K. Tumor cell apoptosis induced by nanoparticle conjugate in combination with radiation therapy. Nanotechnology. 2010 Nov 26;21(47):475103. Epub 2010 Oct 29.

Sheng K, Molloy JA, Larner JM, Read PW. A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol. 2007 Feb;82(2):174-8